Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,933
Closed -$255K 159
2025
Q2
$255K Buy
+18,933
New +$259K ﹤0.01% 1063
2022
Q3
Sell
-7,020
Closed -$218K 1138
2022
Q2
$218K Sell
7,020
-34,280
-83% -$1.07M ﹤0.01% 1067
2022
Q1
$1.4M Sell
41,300
-24,100
-37% -$860K ﹤0.01% 896
2021
Q4
$2.76M Sell
65,400
-18,700
-22% -$737K 0.01% 787
2021
Q3
$3.44M Sell
84,100
-752,800
-90% -$29.4M 0.01% 765
2021
Q2
$29.7M Buy
836,900
+376,100
+82% +$12.2M 0.08% 277
2021
Q1
$13.3M Buy
460,800
+2,700
+0.6% +$77.9K 0.04% 452
2020
Q4
$12.9M Sell
458,100
-40,800
-8% -$1.05M 0.04% 437
2020
Q3
$11.2M Buy
+498,900
New +$10.4M 0.04% 418

Other funds holding AVTR

Axa's AVTR Position: Q3 2025 in Review

Axa sold out of Avantor (AVTR) in Q3 2025, closing a stake of 18,933 shares — an estimated $255K sold.

Axa first reported a position in AVTR in Q3 2020 and held it in 9 quarters. The position peaked at $29.7M in Q2 2021. 466 funds tracked by Wall St. Rank hold AVTR as of Q3 2025.

  • Axa reported no remaining Avantor position as of Q3 2025 after selling out during the quarter.
  • Axa sold 18,933 Avantor shares in Q3 2025, an estimated $255K.
  • Axa first reported a position in Avantor in Q3 2020 and held it in 9 quarters.
  • Axa's Avantor position peaked at $29.7M in Q2 2021.
  • 466 funds tracked by Wall St. Rank held Avantor as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.